Effects of Continuous Perioperative Esketamine Infusion on Postoperative Depression in Breast Cancer Patients: A Randomized Controlled Double-Blind Trial.
Drug Design, Development and Therapy October 29, 2025 Mengting Shen, Ye Xuan, Kaiyu Chen et al.
Background: Comorbid depressive symptoms are prevalent in patients with breast cancer, which adversely impacts postoperative recovery outcomes. Esketamine has emerged as a promising intervention for perioperative depression due to its rapid and sustained effects. This study aims to investigate the impact of the continuous intravenous infusion of esketamine during the perioperative period on...
DOI: 10.2147/dddt.s540781 (opens in new tab)
Full text (opens in new tab)
Esketamine
Humans
Breast neoplasms
Antidepressive agents
+12